No abstract available
Publication types
-
Comment
-
Editorial
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Angiotensin Receptor Antagonists*
-
Anti-Inflammatory Agents / metabolism
-
Anti-Inflammatory Agents / pharmacology
-
Antihypertensive Agents / pharmacology*
-
Biotransformation
-
Cyclooxygenase 2
-
Humans
-
Imidazoline Receptors
-
Inflammation / drug therapy
-
Inflammation / metabolism
-
Isoenzymes / antagonists & inhibitors
-
Isoenzymes / metabolism
-
Losartan / analogs & derivatives
-
Losartan / metabolism
-
Losartan / pharmacology*
-
Membrane Proteins
-
Myocardium / metabolism
-
Platelet Aggregation Inhibitors / metabolism
-
Platelet Aggregation Inhibitors / pharmacology
-
Prostaglandin-Endoperoxide Synthases / metabolism
-
Prostaglandins / metabolism
-
Receptor, Angiotensin, Type 1
-
Receptors, Angiotensin / metabolism*
-
Receptors, Drug / antagonists & inhibitors
-
Receptors, Tachykinin / antagonists & inhibitors
-
Receptors, Thromboxane / antagonists & inhibitors
-
Signal Transduction / drug effects
-
Signal Transduction / physiology
Substances
-
Angiotensin Receptor Antagonists
-
Anti-Inflammatory Agents
-
Antihypertensive Agents
-
Imidazoline Receptors
-
Isoenzymes
-
Membrane Proteins
-
Platelet Aggregation Inhibitors
-
Prostaglandins
-
Receptor, Angiotensin, Type 1
-
Receptors, Angiotensin
-
Receptors, Drug
-
Receptors, Tachykinin
-
Receptors, Thromboxane
-
Cyclooxygenase 2
-
PTGS2 protein, human
-
Prostaglandin-Endoperoxide Synthases
-
Losartan